Postural tachycardia syndrome: A heterogeneous and multifactorial disorder

Mayo Clinic Proceedings

Volumn 87, Issue 12, 2012, Pages 1214-1225

  Benarroch, Eduardo E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPROSTOL; FLUDROCORTISONE; MIDODRINE; PROPRANOLOL; PYRIDOSTIGMINE; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; AUTONOMIC NEUROPATHY; BEHAVIOR THERAPY; BLADDER DYSFUNCTION; CHRONIC DISEASE; CHRONIC PAIN; CLINICAL EVALUATION; COMORBIDITY; DIARRHEA; DRUG INDUCED HEADACHE; EHLERS DANLOS SYNDROME; EXERCISE; EXERCISE INTOLERANCE; FATIGUE; FEMORAL NEUROPATHY; FIBROMYALGIA; FLUID INTAKE; GASTROINTESTINAL MOTILITY DISORDER; HEADACHE; HUMAN; HYPOTENSION; HYPOVOLEMIA; INSOMNIA; MEDICAL HISTORY; MIGRAINE; NAUSEA; NEUROLOGIC DISEASE; ORTHOSTATIC INTOLERANCE; OVERACTIVE BLADDER; PATHOPHYSIOLOGY; PATIENT ATTITUDE; PATIENT EDUCATION; PHYSICAL ACTIVITY; PHYSICAL DISEASE; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; PROTECTIVE CLOTHING; QUALITY OF LIFE; REVIEW; SIDE EFFECT; SODIUM INTAKE; SYMPTOM; URINE RETENTION; VENOUS STASIS; VERTIGO; VISCERAL PAIN; VOMITING;

EID: 84872905713     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2012.08.013     Document Type: Review

References (97)

1. Low PA, Opfer-Gehrking TL, Textor SC, et al. Postural tachycardia syndrome (POTS). Neurology. 1995;45(4, suppl 5):S19- S25.
2. Low PA, Sandroni P, Joyner M, Shen WK. Postural tachycardia syndrome (POTS). J Cardiovasc Electrophysiol. 2009;20(3):352-358.
3. Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21(2):69-72.
4. Parsaik AT, Allison TG, Singer W, et al. Deconditioning in patients with orthostatic intolerance [published online ahead of print September 19, 2012]. Neurology. 2012. In press.
5. Singer W, Sletten DM, Opfer-Gehrking TL, Brands CK, Fischer PR, Low PA. Postural tachycardia in children and adolescents: what is abnormal? J Pediatr. 2012;160(2):222-226.
6. Sandroni P, Opfer-Gehrking TL, McPhee BR, Low PA. Postural tachycardia syndrome: clinical features and follow-up study. Mayo Clin Proc. 1999;74(11):1106-1110.
7. Thieben MJ, Sandroni P, Sletten DM, et al. Postural orthostatic tachycardia syndrome: the Mayo Clinic experience. Mayo Clin Proc. 2007;82(3):308-313.
8. Medow MS, Stewart JM. The postural tachycardia syndrome. Cardiol Rev. 2007;15(2):67-75.
9. Carew S, Connor MO, Cooke J, et al. A review of postural orthostatic tachycardia syndrome. Europace. 2009;11(1):18-25.
10. Wieling W, Thijs RD, van Dijk N, Wilde AA, Benditt DG, van Dijk JG. Symptoms and signs of syncope: a review of the link between physiology and clinical clues. Brain. 2009;132(pt 10):2630-2642.
11. Alshekhlee A, Guerch M, Ridha F, Mcneeley K, Chelimsky TC. Postural tachycardia syndrome with asystole on head-up tilt. Clin Auton Res. 2008;18(1):36-39.
12. Mathias CJ, Low DA, Iodice V, Owens AP, Kirbis M, Grahame R. Postural tachycardia syndrome - current experience and concepts. Nat Rev Neurol. 2011;8(1):22-34.
13. Garland EM, Raj SR, Black BK, Harris PA, Robertson D. The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome. Neurology. 2007;69(8):790-798.
14. Jacob G, Garland EM, Costa F, et al. Beta2-adrenoceptor genotype and function affect hemodynamic profile heterogeneity in postural tachycardia syndrome. Hypertension. 2006; 47(3):421-427.
15. Nickander KK, Carlson PJ, Urrutia RA, Camilleri M, Low PA. A screen of candidate genes and influence of beta2-adrenergic receptor genotypes in postural tachycardia syndrome. Auton Neurosci. 2005;120(1-2):97-103.
16. Stewart JM, Montgomery LD. Regional blood volume and peripheral blood flow in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol. 2004;287(3):H1319-H1327.
17. Jacob G, Costa F, Shannon JR, et al. The neuropathic postural tachycardia syndrome. N Engl J Med. 2000;343(14):1008-1014.
18. Stewart JM. Pooling in chronic orthostatic intolerance: arterial vasoconstrictive but not venous compliance defects. Circulation. 2002;105(19):2274-2281.
19. Haensch CA, Lerch H, Schlemmer H, Jigalin A, Isenmann S. Cardiac neurotransmission imaging with 123I-meta-iodobenzylguanidine in postural tachycardia syndrome. J Neurol Neurosurg Psychiatry. 2010;81(3):339-343.
20. Streeten DH. Pathogenesis of hyperadrenergic orthostatic hypotension: evidence of disordered venous innervation exclusively in the lower limbs. J Clin Invest. 1990;86(5):1582-1588.
21. Raj SR. The postural tachycardia syndrome (POTS): pathophysiology, diagnosis & management. Indian Pacing Electrophysiol J. 2006;6(2):84-99.
22. Shannon JR, Flattem NL, Jordan J, et al. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med. 2000;342(8):541-549.
23. Shibao C, Arzubiaga C, Roberts LJ II, et al. Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders. Hypertension. 2005;45(3):385-390.
24. Manger WM. The protean manifestations of pheochromocytoma. Horm Metab Res. 2009;41(9):658-663.
25. Misawa T, Mizusawa H. Anti-VGKC antibody-associated limbic encephalitis/Morvan syndrome [in Japanese]. Brain Nerve. 2010;62(4):339-345.
26. Streeten DH, Thomas D, Bell DS. The roles of orthostatic hypotension, orthostatic tachycardia, and subnormal erythrocyte volume in the pathogenesis of the chronic fatigue syndrome. Am J Med Sci. 2000;320(1):1-8.
27. Raj SR, Robertson D. Blood volume perturbations in the postural tachycardia syndrome. Am J Med Sci. 2007;334(1):57-60.
28. Stewart JM, Ocon AJ, Clarke D, Taneja I, Medow MS. Defects in cutaneous angiotensin-converting enzyme 2 and angiotensin- (1-7) production in postural tachycardia syndrome. Hypertension. 2009;53(5):767-774.
29. Fu Q, Vangundy TB, Galbreath MM, et al. Cardiac origins of the postural orthostatic tachycardia syndrome. J Am Coll Cardiol. 2010;55(25):2858-2868.
30. Masuki S, Eisenach JH, Schrage WG, et al. Reduced stroke volume during exercise in postural tachycardia syndrome. J Appl Physiol. 2007;103(4):1128- 1135.
31. Joyner MJ, Masuki S. POTS versus deconditioning: the same or different? Clin Auton Res. 2008;18(6):300-307.
32. Hasser EM, Moffitt JA. Regulation of sympathetic nervous system function after cardiovascular deconditioning. Ann N Y Acad Sci. 2001;940:454-468.
33. Xiao X, Mukkamala R, Sheynberg N, Williams GH, Cohen RJ. Effects of prolonged bed rest on the total peripheral resistance baroreflex. Comput Cardiol. 2002;29:53-56.
34. Dyckman DJ, Sauder CL, Ray CA. Effects of short-term and prolonged bed rest on the vestibulosympathetic reflex. Am J Physiol Heart Circ Physiol. 2012;302(1):H368-H374.
35. Pawelczyk JA, Zuckerman JH, Blomqvist CG, Levine BD. Regulation of muscle sympathetic nerve activity after bed rest deconditioning. Am J Physiol Heart Circ Physiol. 2001;280(5): H2230-H2239.
36. Iwasaki K, Zhang R, Perhonen MA, Zuckerman JH, Levine BD. Reduced baroreflex control of heart period after bed rest is normalized by acute plasma volume restoration. Am J Physiol Regul Integr Comp Physiol. 2004;287(5):R1256- R1262.
37. Ojha A, Chelimsky TC, Chelimsky G. Comorbidities in pediatric patients with postural orthostatic tachycardia syndrome. J Pediatr. 2011;158(1):20-23.
38. Adibi P, Behzad E, Shafieeyan M, Toghiani A. Upper functional gastrointestinal disorders in young adults. Med Arh. 2012;66(2):89-91.
39. Fukudo S, Kuwano H, Miwa H. Management and pathophysiology of functional gastrointestinal disorders. Digestion. 2012; 85(2):85-89.
40. Grover M, Drossman DA. Functional abdominal pain. Curr Gastroenterol Rep. 2010;12(5):391-398.
41. Koloski NA, Jones M, Kalantar J, Weltman M, Zaguirre J, Talley NJ. The brain-gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut. 2012;61(9):1284-1290.
42. Wu JC. Psychological co-morbidity in functional gastrointestinal disorders: epidemiology, mechanisms and management. J Neurogastroenterol Motil. 2012;18(1):13-18.
43. Ocon AJ, Messer ZR, Medow MS, Stewart JM. Increasing orthostatic stress impairs neurocognitive functioning in chronic fatigue syndrome with postural tachycardia syndrome. Clin Sci (Lond). 2012;122(5):227-238.
44. Bagai K, Song Y, Ling JF, et al. Sleep disturbances and diminished quality of life in postural tachycardia syndrome. J Clin Sleep Med. 2011;7(2):204-210.
45. Okamoto LE, Raj SR, Peltier A, et al. Neurohumoral and haemodynamic profile in postural tachycardia and chronic fatigue syndromes. Clin Sci (Lond). 2012;122(4):183-192.
46. Staud R. Autonomic dysfunction in fibromyalgia syndrome: postural orthostatic tachycardia. Curr Rheumatol Rep. 2008; 10(6):463-466.
47. Gazit Y, Nahir AM, Grahame R, Jacob G. Dysautonomia in the joint hypermobility syndrome. Am J Med. 2003;115(1):33-40.
48. Kanjwal K, Saeed B, Karabin B, Kanjwal Y, Grubb BP. Comparative clinical profile of postural orthostatic tachycardia patients with and without joint hypermobility syndrome. Indian Pacing Electrophysiol J. 2010;10(4):173-178.
49. Keller NR, Robertson D. Familial orthostatic tachycardia. Curr Opin Cardiol. 2006;21(3):173-179.
50. O'Connell M, Burrows NP, van Vlijmen-Willems MJ, Clark SM, Schalkwijk J. Tenascin-X deficiency and Ehlers-Danlos syndrome: a case report and review of the literature. Br J Dermatol. 2010;163(6):1340-1345.
51. Sacheti A, Szemere J, Bernstein B, Tafas T, Schechter N, Tsipouras P. Chronic pain is a manifestation of the Ehlers- Danlos syndrome. J Pain Symptom Manage. 1997;14(2):88-93.
52. Baeza-Velasco C, Gely-Nargeot MC, Vilarrasa AB, Fenetrier C, Bravo JF. Association between psychopathological factors and joint hypermobility syndrome in a group of undergraduates from a French university. Int J Psychiatry Med. 2011;41(2):187-201.
53. Mack KJ, Johnson JN, Rowe PC. Orthostatic intolerance and the headache patient. Semin Pediatr Neurol. 2010;17(2):109-116.
54. Mathys J, Beiser I, Maurer G, Humm AM. Orthostatic headache with tachycardia [in German]. Praxis (Bern 1994). 2011; 100(10):613-616.
55. Mokri B, Low PA. Orthostatic headaches without CSF leak in postural tachycardia syndrome. Neurology. 2003;61(7):980-982.
56. Prilipko O, Dehdashti AR, Zaim S, Seeck M. Orthostatic intolerance and syncope associated with Chiari type I malformation. J Neurol Neurosurg Psychiatry. 2005;76(7):1034-1036.
57. Pasupuleti DV, Vedre A. Postural orthostatic tachycardia warrants investigation of Chiari I malformation as a possible cause. Cardiology. 2005;103(1):55-56.
58. Nogués M, Delorme R, Saadia D, Heidel K, Benarroch E. Postural tachycardia syndrome in syringomyelia: response to fludrocortisone and beta-blockers. Clin Auton Res. 2001;11(4):265-267.
59. Garland EM, Robertson D. Chiari I malformation as a cause of orthostatic intolerance symptoms: a media myth? Am J Med. 2001;111(7):546-552.
60. Kanjwal K, Karabin B, Kanjwal Y, Grubb BP. Autonomic dysfunction presenting as postural tachycardia syndrome following traumatic brain injury. Cardiol J. 2010;17(5):482-487.
61. Ruckenstein MJ, Staab JP. Chronic subjective dizziness. Otolaryngol Clin North Am. 2009;42(1):71-77, ix.
62. Dieterich M, Krafczyk S, Querner V, Brandt T. Somatoform phobic postural vertigo and psychogenic disorders of stance and gait. Adv Neurol. 2001;87:225-233.
63. Carter JR, Ray CA. Sympathetic responses to vestibular activation in humans. Am J Physiol Regul Integr Comp Physiol. 2008; 294(3):R681-R688.
64. Benrud-Larson LM, Dewar MS, Sandroni P, Rummans TA, Haythornthwaite JA, Low PA. Quality of life in patients with postural tachycardia syndrome. Mayo Clin Proc. 2002;77(6):531-537.
65. Staud R. Brain imaging in fibromyalgia syndrome. Clin Exp Rheumatol. 2011;29(6, suppl 69):S109-S117.
66. Clauw DJ, Arnold LM, McCarberg BH; FibroCollaborative. The science of fibromyalgia. Mayo Clin Proc. 2011;86(9):907-911.
67. Jurysta F, Lanquart JP, Sputaels V, et al. The impact of chronic primary insomnia on the heart rate - EEG variability link. Clin Neurophysiol. 2009;120(6):1054-1060.
68. Barnett KJ, Cooper NJ. The effects of a poor night sleep on mood, cognitive, autonomic and electrophysiological measures. J Integr Neurosci. 2008;7(3):405-420.
69. Shoemaker JK, Usselman CW, Rothwell A, Wong SW. Altered cortical activation patterns associated with baroreflex unloading following 24 hours of physical deconditioning [published online ahead of print May 21, 2012]. Exp Physiol. 2012.
70. Saper CB. The central autonomic nervous system: conscious visceral perception and autonomic pattern generation. Annu Rev Neurosci. 2002;25:433-469.
71. Craig AD. Interoception: the sense of the physiological condition of the body. Curr Opin Neurobiol. 2003;13(4):500-505.
72. Critchley HD. Neural mechanisms of autonomic, affective, and cognitive integration. J Comp Neurol. 2005;493(1):154-166.
73. Critchley HD, Nagai Y, Gray MA, Mathias CJ. Dissecting axes of autonomic control in humans: insights from neuroimaging. Auton Neurosci. 2011;161(1-2):34-42.
74. Holstege G, Bandler R, Saper CB. The emotional motor system. Prog Brain Res. 1996;107:3-6.
75. Fuller PM, Jones TA, Jones SM, Fuller CA. Evidence for macular gravity receptor modulation of hypothalamic, limbic and autonomic nuclei. Neuroscience. 2004;129(2):461-471.
76. Benarroch EE. The arterial baroreflex: functional organization and involvement in neurologic disease. Neurology. 2008; 71(21):1733-1738.
77. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci. 2006;7(5):335-346.
78. LeDoux J. Rethinking the emotional brain. Neuron. 2012;73(4):653-676.
79. [published correction appears in Neuron. 2012;73(5):1052]
80. Critchley HD. Psychophysiology of neural, cognitive and affective integration: fMRI and autonomic indicants. Int J Psychophysiol. 2009;73(2):88-94.
81. Kimmerly DS, O'Leary DD, Menon RS, Gati JS, Shoemaker JK. Cortical regions associated with autonomic cardiovascular regulation during lower body negative pressure in humans. J Physiol. 2005;569(pt 1):331-345.
82. Buckholtz JW, Meyer-Lindenberg A. Psychopathology and the human connectome: toward a transdiagnostic model of risk for mental illness. Neuron. 2012;74(6):990-1004.
83. Legrain V, Iannetti GD, Plaghki L, Mouraux A. The pain matrix reloaded: a salience detection system for the body. Prog Neurobiol. 2011;93(1):111-124.
84. Henry DE, Chiodo AE, Yang W. Central nervous system reorganization in a variety of chronic pain states: a review. PM R. 2011;3(12):1116-1125.
85. Abi-Samra F, Maloney JD, Fouad-Tarazi FM, Castle LW. The usefulness of head-up tilt testing and hemodynamic investigations in the workup of syncope of unknown origin. Pacing Clin Electrophysiol. 1988;11(8):1202-1214.
86. Wieling W, van Lieshout JJ, van Leeuwen AM. Physical manoeuvres that reduce postural hypotension in autonomic failure. Clin Auton Res. 1993;3(1):57-65.
87. Krediet CT, de Bruin IG, Ganzeboom KS, Linzer M, van Lieshout JJ, Wieling W. Leg crossing, muscle tensing, squatting, and the crash position are effective against vasovagal reactions solely through increases in cardiac output. J Appl Physiol. 2005; 99(5):1697-1703.
88. Gordon VM, Opfer-Gehrking TL, Novak V, Low PA. Hemodynamic and symptomatic effects of acute interventions on tilt in patients with postural tachycardia syndrome. Clin Auton Res. 2000;10(1):29-33.
89. Smit AA, Wieling W, Fujimura J, et al. Use of lower abdominal compression to combat orthostatic hypotension in patients with autonomic dysfunction. Clin Auton Res. 2004;14(3):167-175.
90. Shibata S, Fu Q, Bivens TB, Hastings JL, Wang W, Levine BB. Short-term exercise training improves the cardiovascular response to exercise in the postural orthostatic tachycardia syndrome. J Physiol. 2012;590(pt 15):3495-3505.
91. Freitas J, Santos R, Azevedo E, Costa O, Carvalho M, de Freitas AF. Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone. Clin Auton Res. 2000;10(5):293-299.
92. Chen L, Wang L, Sun J, et al. Midodrine hydrochloride is effective in the treatment of children with postural orthostatic tachycardia syndrome. Circ J. 2011;75(4):927-931.
93. Raj SR, Black BK, Biaggioni I, et al. Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more. Circulation. 2009;120(9):725-734.
94. Yusuf S, Camm AJ. The sinus tachycardias. Nat Clin Pract Cardiovasc Med. 2005;2(1):44-52.
95. Singer W, Opfer-Gehrking TL, Nickander KK, Hines SM, Low PA. Acetylcholinesterase inhibition in patients with orthostatic intolerance. J Clin Neurophysiol. 2006;23(5):476-481.
96. Raj SR, Black BK, Biaggioni I, Harris PA, Robertson D. Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome. Circulation. 2005;111(21):2734- 2740.
97. Kanjwal K, Karabin B, Sheikh M, et al. Pyridostigmine in the treatment of postural orthostatic tachycardia: a singlecenter experience. Pacing Clin Electrophysiol. 2011;34(6):750-755.